Pharmaceutical Executive, Jun 1, 2011 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Jun 1, 2011
Features
Filling in the Bigger Picture
Part II of The Avoca Group's 2011 CRO survey on clinical development outsourcing relationships
Emerging Pharma Leaders 2011
Meet 2011's Emerging Pharma Leaders—Can these 30 trendsetters build competitive scale from scarcity?
Are You Ready for the New China?
By Jon Zifferblatt
Foreign investors need the wiles of a tigress as the government revisits the idea of private healthcare
2011 Dealmakers Outlook
By William Looney
With Yankee stadium as the backdrop, Pharm Exec convened its annual panel of eight business development experts to crack the bat on best practice in licensing and M&A for the year ahead.
From the Editor
Heading for the Horizon
By William Looney
Now that government payers are turning to pharma to bridge budgetary shortfalls it's best to think long-term
Columns
Educating Physicians
By Jill Wechsler
FDA's opiod REMS implies there is still value in industry-sponsored CME
Getting IT Together
By Jennifer Ringler
NeHC's new Consumer Consortium is promoting a new stakeholder agenda to improve patient knowledge
Managing Product Lifecycle
Patent expiries are inevitable, but brand teams should look to graduate the sales curve
Optimizing your Value with Payers
Successful negotiations require a willingness to take risks and an ability to adapt
To Genzyme, Quality Data Depends on Quality Governance
The payoff is superior performance in key areas such as clinical trials
To Screen or Not to Screen?
By Ben Comer
What do our genetics tell us about our predisposition to certain diseases?
A Lack of Information
By Reflector
Why has the EU still not managed to update its rules on information about medicines?

ADVERTISEMENT

Click here